Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 175 of 591 entries
View as:

64 Cu-DOTA-alendronate PET Imaging in Localizing and Characterizing Breast Calcifications in Participants Before Undergoing Mastectomy

Phase: N/A Priority: Normal
NCT ID: NCT03542695 Org: User:
Start: 11/03/21 End: 05/31/24 Due: 05/31/25

Blood Samples to Identify Biomarkers in Patients Treated With Cyclophosphamide After Donor Stem Cell Transplant

Phase: N/A Priority: Normal
NCT ID: NCT04160390 Org: User:
Start: 11/13/18 End: 04/24/27 Due: 04/24/28

Busulfan, Etoposide, and Total-Body Irradiation in Treating Patients Undergoing Donor Stem Cell or Bone Marrow Transplant for Advanced Hematologic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00534430 Org: User:
Start: 02/29/00 End: 03/18/26 Due: 03/18/27

Glasdegib-Based Treatment Combinations for the Treatment of Patients With Relapsed Acute Myeloid Leukemia Who Have Undergone Hematopoietic Cell Transplantation

Phase: N/A Priority: Normal
NCT ID: NCT04655391 Org: User:
Start: 06/25/22 End: 12/15/23 Due: 12/15/24

Culturally Adapted Parenting Intervention for Spanish-Speaking Parents in Improving Outcomes of Younger Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia Survivors at Risk for Late Neurocognitive Effects

Phase: N/A Priority: Normal
NCT ID: NCT02559557 Org: User:
Start: 10/22/15 End: 04/18/16 Due: 04/18/17

Early Detection of Advanced Adenomas and Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06342440 Org: User:
Start: 03/15/20 End: 06/18/26 Due: 06/18/27

Geriatric Assessment in Predicting Chemotherapy Toxicity and Vulnerabilities in Older Patients With Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02517034 Org: User:
Start: 08/04/15 End: 02/28/26 Due: 02/28/27

Multiple Doses of Neural Stem Cell Virotherapy (NSC-CRAd-S-pk7) for the Treatment of Recurrent High-Grade Gliomas

Phase: N/A Priority: Normal
NCT ID: NCT05139056 Org: User:
Start: 05/02/23 End: 08/07/25 Due: 08/07/26

Combination Chemotherapy, Total Body Irradiation, and Donor Blood Stem Cell Transplant in Treating Patients With Secondary Myelofibrosis

Phase: N/A Priority: Normal
NCT ID: NCT03118492 Org: User:
Start: 05/24/17 End: 05/26/26 Due: 05/26/27

Spatiotemporal Stereotactic Body Radiation Therapy for the Treatment of Patients With Polymetastatic Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT05733949 Org: User:
Start: 04/27/23 End: 10/11/27 Due: 10/11/28

Cognitive Function in Older Women With Stage I, Stage II, or Stage III Breast Cancer Receiving Hormone Therapy

Phase: N/A Priority: Normal
NCT ID: NCT00681928 Org: User:
Start: 10/31/07 End: 01/31/11 Due: 01/31/12

App-Based Mindfulness Intervention for the Improvement of Quality of Life in Patients With Metastatic Renal Cell Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04788095 Org: User:
Start: 08/23/21 End: 06/02/25 Due: 06/02/26

Addressing Stigma in Screening and Diagnostic Delay for Cervical Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01287871 Org: User:
Start: 01/31/11 End: 12/31/25 Due: 12/31/26

An Exercise Intervention Trial to Reduce Symptoms & Improve Clinical Outcomes of Platinum-Based Treatment in Ovarian Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT02878980 Org: User:
Start: 09/02/16 End: 12/31/18 Due: 12/31/19

Palliative Care in Improving Quality of Life and Symptoms in Patients With Stage III-IV Pancreatic or Ovarian Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01927393 Org: User:
Start: 12/31/14 End: - Due: -

Genetically Engineered Lymphocyte Therapy After Peripheral Blood Stem Cell Transplant in Treating Patients With High-Risk, Intermediate-Grade, B-cell Non-Hodgkin Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT01318317 Org: User:
Start: 09/19/11 End: 02/26/26 Due: 02/26/27

Genetically Modified T-cell Immunotherapy in Treating Patients With Relapsed/Refractory Acute Myeloid Leukemia and Persistent/Recurrent Blastic Plasmacytoid Dendritic Cell Neoplasm

Phase: N/A Priority: Normal
NCT ID: NCT02159495 Org: User:
Start: 12/15/15 End: 08/18/25 Due: 08/18/26

IRX-2, Cyclophosphamide, and Nivolumab in Treating Patients With Recurrent or Metastatic and Refractory Liver Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03655002 Org: User:
Start: 02/21/19 End: 03/30/26 Due: 03/30/27

Brentuximab Vedotin, Cyclosporine, and Verapamil Hydrochloride in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT03013933 Org: User:
Start: 05/03/17 End: 05/24/22 Due: 05/24/23

Physical Activity Intervention Before and After Surgery in Older Adults With Lung Cancer and Their Family Caregivers

Phase: N/A Priority: Normal
NCT ID: NCT04085081 Org: User:
Start: 05/15/21 End: 11/01/22 Due: 11/01/23

MiRisten for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT07025564 Org: User:
Start: 02/28/26 End: 05/27/27 Due: 05/27/28

Eat, Move, Live Intervention in Reducing Chronic Disease Risk in Medically Vulnerable Communities

Phase: N/A Priority: Normal
NCT ID: NCT02513407 Org: User:
Start: 04/06/16 End: 07/15/25 Due: 07/15/26

CC-486 and Nivolumab for the Treatment of Hodgkin Lymphoma Refractory to PD-1 Therapy or Relapsed

Phase: N/A Priority: Normal
NCT ID: NCT05162976 Org: User:
Start: 01/03/22 End: 05/12/26 Due: 05/12/27

Psychosocial Support for African-American, Latina-American, or European-American Cervical Cancer Survivors

Phase: N/A Priority: Normal
NCT ID: NCT00915889 Org: User:
Start: 11/30/06 End: 05/31/12 Due: 05/31/13

A Phase II Study of Allo-HCT for B-Cell NHL Using Zevalin, Fludarabine and Melphalan

Phase: N/A Priority: Normal
NCT ID: NCT00577278 Org: User:
Start: 10/03/07 End: 12/14/23 Due: 12/14/24